Logo

Shares in Sequenom Jump 9 Percent On News of DNA Methylation Service Business Launch

Oct 27, 2005

NEW YORK, Oct. 27 (GenomeWeb News) - Sequenom introduced a DNA methylation and quantitative gene expression analysis service business yesterday.

 

Shares in the company were trading up 9 percent, or $.06, at $.72 in mid-afternoon trading.

 

Through the service, researchers can access Sequenom's MassArray solution for quantitative analysis and profiling of DNA methylation and gene expression. The company applies its iPLEX multiplexing assay to quantitative methylation profiling and quantitative gene expression analysis.

 

Sequenom said it intends to make DNA methylation and QGE analysis available as application products for the MassARRAY platform in the first quarter of 2006.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.